about
Lead encephalopathy due to traditional medicinesHow vaccine safety can become political--the example of polio in NigeriaPrevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics.In silico prediction of adverse drug reactions and toxicities based on structural, biological and clinical data.A descriptive analysis of post-chemotherapy development of interstitial lung disease using spontaneous reporting data in Japan.Sirolimus early graft nephrotoxicity: clinical and experimental data.Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.Hepatic effects of duloxetine-I: non-clinical and clinical trial data.Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.Mechanisms of drug induced QT interval prolongation.Adverse dermatological reactions in rheumatoid arthritis patients treated with etanercept, an anti-TNFalpha drug.Safety of the thrombopoiesis-stimulating agents for the treatment of immune thrombocytopenia.Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia.Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction.Severe coagulation disorder and thrombocytopenia associated with Tigecycline - Case report and review of literature.CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisUse of metformin and survival of diabetic women with breast cancerReporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review.Antihistamines: past answers and present questions.Domperidone and long QT syndrome.Patterns of self-medication with medicinal plants and related adverse events--a South American survey.The psychoactive effects of antidepressants and their association with suicidality.Clozapine safety, 35 years later.Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?A systematic review of the efficacy and safety of desipramine for treating ADHD.Implemented data mining and signal management systems on spontaneous reporting systems' databases and their availability to the scientific community - a systematic review.Specific TNF-alpha inhibition in cerebral aneurysm formation and subarachnoid hemorrhage.Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage.Exploring the use of estrogen & progesterone replacement therapy in subarachnoid hemorrhage.Restless leg syndrome associated with atypical antipsychotics: current status, pathophysiology, and clinical implications.Tolerability of amine uptake inhibitors in urologic diseases.Side effects of clozapine and some other psychoactive drugs.Clinical profile of relaxin, a possible new drug for human use.QT alterations in psychopharmacology: proven candidates and suspects.Other drugs acting on nervous system associated with QT-interval prolongation.Severe hyponatremia and other electrolyte disturbances associated with indapamide.Safety and side effects of cannabidiol, a Cannabis sativa constituent.Relaxin as a cardiovascular drug: a promise kept.Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test.Drug-induced hair disorders.
P1433
Q22305778-F24198F0-1CAE-4B32-8CEF-2E96392D328AQ28290279-790A4D71-238D-4EA6-99EE-426330574FF9Q30487038-B8AC222D-E073-4489-B395-5A331FBA17A1Q30561373-0F3A8164-21AB-42C0-83B5-3CE1351EE24FQ30829781-8D4C17A0-785C-4B68-B6BA-B593D6F21550Q31170567-68D1EC81-3809-4C3B-9C35-657D5DF35E72Q31170576-3178653B-90E4-41E8-B625-11EF154E8996Q31170584-EFCABFFD-3D04-4249-A7EE-47678724269BQ31170592-B34ACA00-573A-4956-9710-4A10C2FB3965Q33158454-EB801E1F-5A8E-4212-8FAD-A671F5355CD6Q33380678-040A8864-88AA-4EE2-BB6E-053C2F9FFE1CQ33385046-98358651-200E-4466-9061-64B2F7464AAEQ33426321-77E25681-1E10-4867-9287-D5635225B085Q33427506-E0BB87A1-2320-40E7-B7D3-367D9E478368Q33435536-1714EA41-B227-4322-8F64-47473FBF665BQ33646525-B4465A2D-52F8-4DF2-9124-6EA4FB30439EQ33646542-BBB420F7-D98F-44AB-92F2-8F6C4E984339Q34084774-74433445-B79C-4AB9-85FA-CE5750A0D216Q34102663-FF52F643-14D7-4F51-A1EF-37FAFF4EF585Q34110331-A76A9520-BD3E-4D16-A14A-A8947651E544Q34124944-C0A955D8-2D21-4768-80F1-99373B096D48Q34168580-5CDB6F32-1D3D-4959-B4A7-78F00AB39C1AQ34236367-6EA9860E-D2A9-4F13-9731-8061B5FD0374Q34343545-6FCD1645-3230-4A46-AFB8-C329CC209F58Q34361819-DC1CF070-ECAD-46D5-AFE4-4558472D9A3AQ34370982-603236BC-7E1E-45E6-BCA9-F7E33AAA29A3Q34403730-E0570B8A-469F-475C-A9F7-10F529DC7016Q34403738-62E01275-BF48-4A2C-ADFD-53E1A7CF06A8Q34403745-86978C6E-6694-4DB2-9693-361B5ADC5DA1Q34421410-592BE6E4-D04D-4431-8B5A-DD02E2DC7FF5Q34595378-75A06168-E734-4C46-A73E-05297E874AF6Q34595385-06B6E8C3-CFE2-4000-8F18-41967082390CQ34609000-3839B0B7-4980-421D-9D58-A10417DEA875Q34617497-A4392CF8-A60C-4DFE-86D2-0B93547160D2Q34617504-3A3FE3C0-DC1E-477A-BDBD-71DBE90D2F1DQ34633961-F05C46A3-40D6-4F28-8586-D50AD4AFD1BDQ34634008-F579C052-66B9-4836-B2AA-D88B0EB1F7C9Q34636687-EB8939C8-5B5B-4BAD-BD4F-1447CD0F7E16Q34806302-00A24185-6945-45F5-9E35-518BC63E7A95Q34806314-97404541-C1E7-4049-86FD-A760F3EE009E
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Current Drug Safety
@ast
Current Drug Safety
@en
Current Drug Safety
@es
Current Drug Safety
@it
Current Drug Safety
@nl
type
label
Current Drug Safety
@ast
Current Drug Safety
@en
Current Drug Safety
@es
Current Drug Safety
@it
Current Drug Safety
@nl
prefLabel
Current Drug Safety
@ast
Current Drug Safety
@en
Current Drug Safety
@es
Current Drug Safety
@it
Current Drug Safety
@nl
P3181
P1055
P1058
P1156
5800173386
P1277
P1476
Current Drug Safety
@und